Oncotarget: Cis-acting elements in 3′ UTR mediate post-transcriptional regulation of KRAS

(2:31)

Are Cis-Spliced Fusion Proteins Pathological in More Aggressive Luminal Breast Cancer? | Oncotarget

(1:27)

Oncotarget | Role of Cancer Associated Fibroblasts in Prostate Cancer

(7:21)

Oncotarget: CRISPR Used in Triple Negative Breast Cancer Research

(59)

Uncovering the role of p62 in the development of cisplatin resistance in ovarian cancer

(2:52)

Oncotarget: AKT1(E17K) mutation induces mammary hyperplasia but prevents HER2-driven tumorigenesis

(7:39)

Oncotarget: Metabolic reprogramming of glioblastoma cells sensitizes for apoptosis

(11:5)

The Double-Edge Sword of CRISPR Application for In Vivo Studies | Oncotarget

(1:25)

Niedoceniana roślina. Wystarczy 5 sztuk na tydzień | dr Bartek KRÓCEJ

(8:43)

Microenvironmental stiffness induces metabolic reprogramming in glioblastoma

(4:52)

Anticancer Drugs | Microtubule Inhibitors | Paclitaxel | Docetaxel

(14:15)

Oncology Order Set Demo 2018

(11:36)

Biomarkers of cancer-associated fibroblasts: What we know

(1:49)

Cell Membrane Biomarkers in Triple-Negative Breast Cancer (TNBC) cells from transcriptomic analysis

(15:11)

Ferroptosis: A Hidden Cell Death Pathway I Basic Science Series

(4:51)

Topic 1 Introduction and overview of H\u0026N Contouring (Part 1)

(55:17)

The Mechanism of Cisplatin (New -HD)

(2:50)

Cancer Associated Fibroblast (CAF) and TFG-β interaction with immune cells #Code: 342

(5:37)

Oncotarget: Metal Compounds Induce DNA Instability in Cancer Cells

(51)

Serum Tumor Markers in NSCLC Management | Oncotarget

(1:56)

Oncotarget: Table of Contents - Volume 12, Issue 20

(1:48)

Behind the Study: Anticancer Potential of CLK Kinase Inhibitors 1C8 and GPS167 | Oncotarget

(6:47)

Reducing Bias in Radiology with Topological Data Analysis | Oncotarget

(1:2)

Oncotarget: Dynamic Changes Throughout Pancreatic Cancer Treatment

(53)

Oncotarget: T-Cell-Targeted Immunotherapy for Recurrent HNSCC

(57)